Home07X • FRA
add
Annovis Bio Inc
Previous close
€4.22
Day range
€4.22 - €4.22
Year range
€1.05 - €6.86
Market cap
110.65M USD
Avg Volume
1.37K
P/E ratio
-
Dividend yield
-
Primary exchange
NYSE
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 7.43M | 69.45% |
Net income | -7.26M | 42.53% |
Net profit margin | — | — |
Earnings per share | -0.37 | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 15.29M | 20.97% |
Total assets | 17.19M | 19.69% |
Total liabilities | 4.03M | -44.74% |
Total equity | 13.16M | — |
Shares outstanding | 26.50M | — |
Price to book | 6.49 | — |
Return on assets | -96.20% | — |
Return on capital | -118.07% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -7.26M | 42.53% |
Cash from operations | -3.49M | -8.94% |
Cash from investing | — | — |
Cash from financing | 1.64M | -86.12% |
Net change in cash | -1.84M | -121.34% |
Free cash flow | -851.82K | 49.64% |
About
Founded
2008
Headquarters
Website
Employees
8
